These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6970019)

  • 1. Monitoring heparin anticoagulation and its neutralization.
    Jobes DR; Schwartz AJ; Ellison N; Andrews R; Ruffini RA; Ruffini JJ
    Ann Thorac Surg; 1981 Feb; 31(2):161-6. PubMed ID: 6970019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two methods for heparin monitoring: a semi-automated heparin monitoring device and activated clotting time during extracorporeal circulation.
    Stead SW
    Int J Clin Monit Comput; 1989 Dec; 6(4):247-54. PubMed ID: 2628513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery.
    DeLaria GA; Tyner JJ; Hayes CL; Armstrong BW
    Arch Surg; 1994 Sep; 129(9):944-50; discussion 950-1. PubMed ID: 8080377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery.
    Kuitunen AH; Salmenperä MT; Heinonen J; Rasi VP; Myllylä G
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):221-6. PubMed ID: 1863741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a Statistical Model for Protamine Titration: Effects on Coagulation in Cardiac Surgical Patients.
    Hällgren O; Svenmarker S; Appelblad M
    J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):516-521. PubMed ID: 27712970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of activated clotting time to monitor anticoagulation during cardiac surgery.
    Niinikoski J; Laato M; Laaksonen V; Jalonen J; Inberg MV
    Scand J Thorac Cardiovasc Surg; 1984; 18(1):57-61. PubMed ID: 6609429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin monitoring during cardiopulmonary bypass.
    Saleem A; Shenaq SS; Yawn DH; Harshberger K; Diemunsch P; Mohindra P
    Ann Clin Lab Sci; 1984; 14(6):474-9. PubMed ID: 6508227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP; Castellani WJ; Hodges ED; Yelverton S
    Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.
    Jobes DR; Aitken GL; Shaffer GW
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion requirements in coronary artery surgery with and without the activated clotting time (ACT) technique.
    Preiss DU; Schmidt-Bleibtreu H; Berguson P; Metz G
    Klin Wochenschr; 1985 Mar; 63(6):252-6. PubMed ID: 3872962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.